The store will not work correctly when cookies are disabled.
US8618286, 26
ID: ALA3675253
PubChem CID: 44600411
Max Phase: Preclinical
Molecular Formula: C17H22N4OS2
Molecular Weight: 362.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N/C(=N\c1ccc2c(c1)N(CCNCCO)CCS2)c1cccs1
Standard InChI: InChI=1S/C17H22N4OS2/c18-17(16-2-1-10-23-16)20-13-3-4-15-14(12-13)21(8-11-24-15)7-5-19-6-9-22/h1-4,10,12,19,22H,5-9,11H2,(H2,18,20)
Standard InChI Key: VXRVHTIDELZJKF-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
1.5548 -3.6021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6011 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9020 -3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9050 -5.2502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2059 -5.9988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2089 -7.4996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2490 -8.0981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0312 -5.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4984 -5.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2484 -4.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2447 -3.1359 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
11 18 1 0
18 7 1 0
18 19 2 0
19 4 1 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.52 | Molecular Weight (Monoisotopic): 362.1235 | AlogP: 2.28 | #Rotatable Bonds: 7 |
Polar Surface Area: 73.88 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.08 | CX LogP: 2.11 | CX LogD: 0.00 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.40 | Np Likeness Score: -1.71 |
References
1. (2013) Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, |